The CEO and management team alongside Nick are the only beneficiaries of what has been a long series of market losses and capital raises since ‘The Great Decline’.
As long as the entire management team is drawing a handsome salary from shareholders cash, they will continue to muffle along. A big sweep-out of Nick AND management alongside a plan to move forward would be IMO a refreshing signal.
I don’t think a 5% shareholder’s concerns should be seen as ‘a distraction’ to a MD + CEO who are supposed to be responsible for shareholder value. Probably the most unprofessional release I’ve ever read.
- Forums
- ASX - By Stock
- BCB
- Ann: Notices pursuant to sections 203D and 249D of the Corps Act
Ann: Notices pursuant to sections 203D and 249D of the Corps Act, page-13
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BCB (ASX) to my watchlist
|
|||||
Last
1.7¢ |
Change
-0.002(10.5%) |
Mkt cap ! $48.43M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.7¢ | $118.7K | 6.766M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2461000 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 160660 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2461000 | 0.016 |
11 | 1670110 | 0.015 |
22 | 3255862 | 0.014 |
1 | 300000 | 0.013 |
4 | 262000 | 0.012 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 160660 | 1 |
0.018 | 111982 | 1 |
0.019 | 2167913 | 3 |
0.020 | 989115 | 2 |
0.023 | 1718391 | 8 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
BCB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online